日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of as-needed albuterol-budesonide versus albuterol in patients with asthma aged 12 to <18 years: design of the randomised, double-blind, parallel-group phase IIIb ACADIA trial

一项随机、双盲、平行组 IIIb 期 ACADIA 试验旨在比较按需使用沙丁胺醇-布地奈德与单用沙丁胺醇治疗 12 至 <18 岁哮喘患者的疗效和安全性。

Bacharier, Leonard Benjamin; Raissy, Hengameh; Bardsley, Samuel; Dunsire, Lynn; Hermansson, Erik; Surujbally, Raulin; Sobande, Olami; Murphy, Kevin R

What is the Asthma Impairment and Risk Questionnaire and how can it help patients with asthma? A plain language summary of publications

什么是哮喘损害和风险问卷?它如何帮助哮喘患者?(以下为相关文献的简明摘要)

George, Maureen; Chipps, Bradley E; Beuther, David A; McCann, William; Reibman, Joan; Wise, Robert A; Zeiger, Robert S; Gilbert, Ileen; Eudicone, James M; Gandhi, Hitesh N; Coyne, Karin S; Harding, Gale; Cutts, Katelyn; Ross, Melissa; Murphy, Kevin R

Impact of Lung Function on Asthma Exacerbation Rates in Children Treated with Dupilumab: The VOYAGE Study

肺功能对接受度普利尤单抗治疗的儿童哮喘急性发作率的影响:VOYAGE 研究

Guilbert, Theresa W; Murphy, Kevin R; Hamelmann, Eckard; Ross, Kristie R; Gupta, Atul; Fiocchi, Alessandro; Xia, Changming; Gall, Rebecca; Ledanois, Olivier; Radwan, Amr; Jacob-Nara, Juby A; Rowe, Paul J; Deniz, Yamo

Impact of Utilizing a Composite versus a Symptom-Only Validation Standard in the Development of the Asthma Impairment and Risk Questionnaire

在哮喘损害和风险问卷的开发过程中,采用综合验证标准与仅采用症状验证标准的影响

Chipps, Bradley E; Zeiger, Robert S; Beuther, David A; Wise, Robert A; McCann, William; Reibman, Joan; George, Maureen; Gilbert, Ileen; Eudicone, James M; Coyne, Karin S; Harding, Gale; Murphy, Kevin R

Myofibroblast senescence promotes arrhythmogenic remodeling in the aged infarcted rabbit heart.

肌成纤维细胞衰老促进老年梗死兔心脏发生致心律失常的重塑

Baggett Brett C, Murphy Kevin R, Sengun Elif, Mi Eric, Cao Yueming, Turan Nilufer N, Lu Yichun, Schofield Lorraine, Kim Tae Yun, Kabakov Anatoli Y, Bronk Peter, Qu Zhilin, Camelliti Patrizia, Dubielecka Patrycja, Terentyev Dmitry, Del Monte Federica, Choi Bum-Rak, Sedivy John, Koren Gideon

Identifying Patients for Self-Administration of Omalizumab

确定适合自行注射奥马珠单抗的患者

Murphy, Kevin R; Winders, Tonya; Smith, Brandy; Millette, Lauren; Chipps, Bradley E

Correction to: Identifying Patients for Self-Administration of Omalizumab

更正:识别适合自行注射奥马珠单抗的患者

Murphy, Kevin R; Winders, Tonya; Smith, Brandy; Millette, Lauren; Chipps, Bradley E

Relationship Between Asthma Control as Measured by the Asthma Impairment and Risk Questionnaire (AIRQ) and Patient Perception of Disease Status, Health-Related Quality of Life, and Treatment Adherence

哮喘控制情况(通过哮喘损害和风险问卷 (AIRQ) 测量)与患者对疾病状况的感知、健康相关生活质量和治疗依从性之间的关系

Reibman, Joan; Chipps, Bradley E; Zeiger, Robert S; Beuther, David A; Wise, Robert A; McCann, William; Gilbert, Ileen; Eudicone, James M; Gandhi, Hitesh N; Harding, Gale; Cutts, Katelyn; Coyne, Karin S; Murphy, Kevin R; George, Maureen

Cannabis-related allergies: An international overview and consensus recommendations

大麻相关过敏:国际概览和共识建议

Skypala, Isabel J; Jeimy, Samira; Brucker, Hannelore; Nayak, Ajay P; Decuyper, Ine I; Bernstein, Jonathan A; Connors, Lori; Kanani, Amin; Klimek, Ludger; Lo, Shun Chi Ryan; Murphy, Kevin R; Nanda, Anil; Poole, Jill A; Walusiak-Skorupa, Jolanta; Sussman, Gordon; Zeiger, Joanna S; Goodman, Richard E; Ellis, Anne K; Silvers, William S; Ebo, Didier G

Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines

美国过敏、哮喘和免疫学会新冠病毒疫苗工作组的见解:mRNA SARS-CoV-2疫苗的过敏反应

Murphy, Kevin R; Patel, Niraj C; Ein, Daniel; Hudelson, Mary; Kodoth, Sangeetha; Marshall, Gailen D Jr; Parikh, Purvi; Blaiss, Michael S